nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—CYP19A1—Tamoxifen—pancreatic cancer	0.488	1	CbGbCtD
Etomidate—Pseudoephedrine—TNF—pancreatic cancer	0.00266	0.605	CrCbGaD
Etomidate—Fenoprofen—PTGS2—pancreatic cancer	0.00174	0.395	CrCbGaD
Etomidate—CYP11B1—Metabolism—GLP1R—pancreatic cancer	0.000389	0.000766	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.000387	0.000763	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SSTR2—pancreatic cancer	0.000385	0.000758	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—DPYD—pancreatic cancer	0.000383	0.000754	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000382	0.000752	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GCG—pancreatic cancer	0.00038	0.00075	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CD—pancreatic cancer	0.000373	0.000734	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCKBR—pancreatic cancer	0.000372	0.000732	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000368	0.000725	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000367	0.000722	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC2A2—pancreatic cancer	0.000363	0.000715	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—AGTR1—pancreatic cancer	0.000363	0.000715	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PRSS1—pancreatic cancer	0.000361	0.000711	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000359	0.000708	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CG—pancreatic cancer	0.000355	0.0007	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CD44—pancreatic cancer	0.000355	0.000699	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000352	0.000694	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GAST—pancreatic cancer	0.000352	0.000693	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000347	0.000683	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.000344	0.000679	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNA1—pancreatic cancer	0.000344	0.000677	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PPARG—pancreatic cancer	0.000343	0.000675	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SCT—pancreatic cancer	0.000334	0.000657	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CD44—pancreatic cancer	0.000326	0.000643	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CB—pancreatic cancer	0.000325	0.00064	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000324	0.000638	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000324	0.000638	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—pancreatic cancer	0.000322	0.000634	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNA2—pancreatic cancer	0.00032	0.00063	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GAST—pancreatic cancer	0.00032	0.00063	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.00032	0.00063	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000319	0.000629	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCK—pancreatic cancer	0.000318	0.000627	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000317	0.000624	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000317	0.000624	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000316	0.000622	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ARG2—pancreatic cancer	0.000313	0.000616	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GCG—pancreatic cancer	0.000313	0.000616	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CD—pancreatic cancer	0.000312	0.000615	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00031	0.000611	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CNR2—pancreatic cancer	0.00031	0.000611	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000305	0.000601	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SCT—pancreatic cancer	0.000303	0.000597	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.0003	0.000592	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000299	0.00059	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—STK11—pancreatic cancer	0.000294	0.00058	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000292	0.000575	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRLHR—pancreatic cancer	0.00029	0.000571	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCK—pancreatic cancer	0.000289	0.00057	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CTNNB1—pancreatic cancer	0.000288	0.000568	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CNR2—pancreatic cancer	0.000282	0.000555	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GLP1R—pancreatic cancer	0.000282	0.000555	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CD44—pancreatic cancer	0.000281	0.000554	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTEN—pancreatic cancer	0.000281	0.000553	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000278	0.000547	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCKAR—pancreatic cancer	0.000277	0.000546	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000276	0.000544	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000275	0.000543	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IAPP—pancreatic cancer	0.000275	0.000541	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000275	0.000541	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TYMP—pancreatic cancer	0.000273	0.000539	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000273	0.000538	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ZNRF3—pancreatic cancer	0.000272	0.000537	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ACVR1B—pancreatic cancer	0.000272	0.000537	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CB—pancreatic cancer	0.000272	0.000536	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GCG—pancreatic cancer	0.00027	0.000531	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—pancreatic cancer	0.00027	0.000531	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000266	0.000524	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000264	0.00052	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SRC—pancreatic cancer	0.00026	0.000513	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000255	0.000503	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—STK11—pancreatic cancer	0.000253	0.000499	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TYMS—pancreatic cancer	0.000253	0.000499	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SHH—pancreatic cancer	0.000253	0.000498	CbGpPWpGaD
Etomidate—SLC2A1—Disease—STAT3—pancreatic cancer	0.000251	0.000495	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NRAS—pancreatic cancer	0.00025	0.000494	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IAPP—pancreatic cancer	0.000249	0.000492	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DTX1—pancreatic cancer	0.000246	0.000485	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SSTR3—pancreatic cancer	0.000246	0.000485	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SST—pancreatic cancer	0.000241	0.000475	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	0.000241	0.000474	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.00024	0.000473	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTHLH—pancreatic cancer	0.000239	0.000472	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTCH1—pancreatic cancer	0.000239	0.000472	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000238	0.000469	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SSTR1—pancreatic cancer	0.000236	0.000465	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTEN—pancreatic cancer	0.000235	0.000463	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	0.000234	0.000462	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—pancreatic cancer	0.000233	0.00046	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—pancreatic cancer	0.000233	0.000459	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PPY—pancreatic cancer	0.000232	0.000456	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—pancreatic cancer	0.000228	0.00045	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SSTR2—pancreatic cancer	0.000227	0.000448	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLAU—pancreatic cancer	0.000227	0.000447	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000226	0.000445	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000225	0.000443	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CNR1—pancreatic cancer	0.000223	0.000439	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GLP1R—pancreatic cancer	0.00022	0.000434	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCKBR—pancreatic cancer	0.00022	0.000433	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000219	0.000432	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SST—pancreatic cancer	0.000219	0.000432	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000218	0.00043	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TYMS—pancreatic cancer	0.000218	0.00043	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DPYD—pancreatic cancer	0.000217	0.000427	CbGpPWpGaD
Etomidate—SLC2A1—Disease—KRAS—pancreatic cancer	0.000216	0.000425	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.000215	0.000424	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GCG—pancreatic cancer	0.000215	0.000424	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DTX4—pancreatic cancer	0.000206	0.000407	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GLI1—pancreatic cancer	0.000206	0.000407	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	0.000206	0.000405	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—pancreatic cancer	0.000206	0.000405	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000205	0.000404	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000204	0.000401	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CNR1—pancreatic cancer	0.000202	0.000398	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CG—pancreatic cancer	0.000202	0.000398	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRP1—pancreatic cancer	0.000201	0.000396	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000201	0.000396	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EGF—pancreatic cancer	0.0002	0.000393	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CA—pancreatic cancer	0.000198	0.00039	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000197	0.000387	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GCG—pancreatic cancer	0.000195	0.000385	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.000195	0.000384	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HEY2—pancreatic cancer	0.000193	0.000381	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000192	0.000378	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GAST—pancreatic cancer	0.000189	0.000372	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AGTR1—pancreatic cancer	0.000186	0.000367	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CG—pancreatic cancer	0.000186	0.000366	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—HRAS—pancreatic cancer	0.000184	0.000362	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HRAS—pancreatic cancer	0.000183	0.000361	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	0.000183	0.000361	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—pancreatic cancer	0.000179	0.000353	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000179	0.000353	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SCT—pancreatic cancer	0.000179	0.000353	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HEY1—pancreatic cancer	0.000179	0.000353	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CD—pancreatic cancer	0.000178	0.00035	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—pancreatic cancer	0.000177	0.000349	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCK—pancreatic cancer	0.000171	0.000336	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—HRAS—pancreatic cancer	0.000168	0.000331	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.000168	0.000331	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CNR2—pancreatic cancer	0.000166	0.000328	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GLP1R—pancreatic cancer	0.000166	0.000328	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—pancreatic cancer	0.000166	0.000328	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CA—pancreatic cancer	0.000166	0.000327	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCKAR—pancreatic cancer	0.000164	0.000323	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CD—pancreatic cancer	0.000163	0.000322	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—pancreatic cancer	0.000162	0.000319	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CG—pancreatic cancer	0.00016	0.000315	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CD44—pancreatic cancer	0.000159	0.000314	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—JAG2—pancreatic cancer	0.000159	0.000313	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MEN1—pancreatic cancer	0.000156	0.000308	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000156	0.000307	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CB—pancreatic cancer	0.000155	0.000305	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000155	0.000305	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—pancreatic cancer	0.000154	0.000304	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GCG—pancreatic cancer	0.000153	0.000301	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	0.000149	0.000295	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SHH—pancreatic cancer	0.000149	0.000294	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH4—pancreatic cancer	0.000148	0.000292	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IAPP—pancreatic cancer	0.000147	0.00029	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HRAS—pancreatic cancer	0.000147	0.00029	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—STK11—pancreatic cancer	0.000144	0.000283	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CB—pancreatic cancer	0.000142	0.00028	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTHLH—pancreatic cancer	0.000141	0.000279	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTCH1—pancreatic cancer	0.000141	0.000279	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—pancreatic cancer	0.000141	0.000278	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CD—pancreatic cancer	0.000141	0.000277	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—pancreatic cancer	0.000135	0.000267	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000135	0.000266	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SST—pancreatic cancer	0.000129	0.000255	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000128	0.000251	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—JAG1—pancreatic cancer	0.000127	0.00025	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH3—pancreatic cancer	0.000126	0.000248	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SRC—pancreatic cancer	0.000124	0.000244	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TYMS—pancreatic cancer	0.000124	0.000243	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTEN—pancreatic cancer	0.000123	0.000242	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CB—pancreatic cancer	0.000123	0.000242	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—pancreatic cancer	0.000122	0.000239	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—pancreatic cancer	0.000121	0.000238	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CNR1—pancreatic cancer	0.000119	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NRAS—pancreatic cancer	0.000119	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000116	0.000228	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GCG—pancreatic cancer	0.000115	0.000227	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000112	0.000221	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—pancreatic cancer	0.000111	0.000218	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AGTR1—pancreatic cancer	0.00011	0.000217	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STK11—pancreatic cancer	0.000108	0.000214	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTEN—pancreatic cancer	0.000106	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KRAS—pancreatic cancer	0.000103	0.000202	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000102	0.000201	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—pancreatic cancer	0.0001	0.000198	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.78e-05	0.000193	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.51e-05	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SMAD4—pancreatic cancer	9.5e-05	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CA—pancreatic cancer	9.43e-05	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—pancreatic cancer	9.4e-05	0.000185	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HES1—pancreatic cancer	9.27e-05	0.000183	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—pancreatic cancer	9.13e-05	0.00018	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	9.07e-05	0.000179	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CB—pancreatic cancer	8.88e-05	0.000175	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—pancreatic cancer	8.75e-05	0.000172	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HRAS—pancreatic cancer	8.73e-05	0.000172	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CA—pancreatic cancer	8.67e-05	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—pancreatic cancer	8.53e-05	0.000168	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TERT—pancreatic cancer	8.13e-05	0.00016	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	7.97e-05	0.000157	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIF1A—pancreatic cancer	7.77e-05	0.000153	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSC2—pancreatic cancer	7.75e-05	0.000153	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—pancreatic cancer	7.71e-05	0.000152	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—pancreatic cancer	7.59e-05	0.000149	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CA—pancreatic cancer	7.48e-05	0.000147	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KDR—pancreatic cancer	7.43e-05	0.000146	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—pancreatic cancer	7.09e-05	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NFKBIA—pancreatic cancer	7.07e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH1—pancreatic cancer	7e-05	0.000138	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	6.95e-05	0.000137	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—pancreatic cancer	6.89e-05	0.000136	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CG—pancreatic cancer	6.85e-05	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NRAS—pancreatic cancer	6.85e-05	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGF—pancreatic cancer	6.77e-05	0.000133	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	6.24e-05	0.000123	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—pancreatic cancer	6.11e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	6.02e-05	0.000119	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTEN—pancreatic cancer	6e-05	0.000118	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.96e-05	0.000117	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	5.89e-05	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	5.41e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	5.25e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	5.04e-05	9.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	5.01e-05	9.87e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	4.87e-05	9.6e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	4.83e-05	9.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	4.7e-05	9.25e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	4.65e-05	9.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	4.56e-05	8.98e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	4.53e-05	8.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	4.42e-05	8.71e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	4.24e-05	8.35e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	4.2e-05	8.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	4.09e-05	8.07e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	4.05e-05	7.99e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	4.04e-05	7.97e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	3.77e-05	7.42e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	3.76e-05	7.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	3.68e-05	7.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	3.48e-05	6.86e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—pancreatic cancer	3.46e-05	6.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	3.2e-05	6.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	3.09e-05	6.1e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	2.96e-05	5.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	2.61e-05	5.15e-05	CbGpPWpGaD
